[(68)Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [(177)Lu]Lu-PSMA-617 treatment

INTRODUCTION: Patient eligibility for [(177)Lu]Lu-PSMA therapy remains a challenge, with only 40–60% response rate when patient selection is done based on the lesion uptake (SUV) on [(68)Ga]Ga-PSMA-PET/CT. Prediction of absorbed dose based on this pre-treatment scan could improve patient selection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Steffie M. B., Hofferber, Regina, Privé, Bastiaan M., de Bakker, Maarten, Gotthardt, Martin, Janssen, Marcel, de Lange, Frank, Muselaers, Constantijn H. J., Mehra, Niven, Witjes, J. Alfred, Costa, Pedro F., Nagarajah, James, Konijnenberg, Mark W., Jentzen, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921092/
https://www.ncbi.nlm.nih.gov/pubmed/34623453
http://dx.doi.org/10.1007/s00259-021-05538-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921092/
https://www.ncbi.nlm.nih.gov/pubmed/34623453
http://dx.doi.org/10.1007/s00259-021-05538-2

Ejemplares similares